Showing results (41-50 of 213) with videos related to
Sort By:
Pageof 22
Trends in Immunology|August 24, 2017
cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and DevelopmentKevin W Ng, Erin A Marshall, John C Bell, et al.Current Pharmaceutical Biotechnology|July 12, 2011
Targeted and armed oncolytic poxviruses for cancer: the lead example of JX-594Caroline J Breitbach, Steve H Thorne, John C Bell, et al.Trends in Molecular Medicine|May 4, 2004
Vesicular stomatitis virus: re-inventing the bulletBrian D Lichty, Anthony T Power, David F Stojdl, et al.Expert Opinion on Biological Therapy|August 13, 2008
Development of targeted oncolytic virotherapeutics through translational researchTa-Chiang Liu, Tae-Ho Hwang, John C Bell, et al.Nature Reviews. Cancer|July 4, 2014
Going viral with cancer immunotherapyBrian D Lichty, Caroline J Breitbach, David F Stojdl, et al.Plos Pathogens|January 24, 2014
From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancerCarolina S Ilkow, Stephanie L Swift, John C Bell, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2004
An E1B-19 kDa gene deletion mutant adenovirus demonstrates tumor necrosis factor-enhanced cancer selectivity and enhanced oncolytic potencyTa-Chiang Liu, Gunnel Hallden, Yaohe Wang, et al.Proceedings of the National Academy of Sciences of the United States of America|September 26, 2008
Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysisThi Lien-Anh Nguyên, Hesham Abdelbary, Meztli Arguello, et al.Journal of Visualized Experiments : Jove|July 7, 2011
Ex vivo infection of live tissue with oncolytic virusesJean-Simon Diallo, Dominic Roy, Hesham Abdelbary, et al.Cytokine & Growth Factor Reviews|May 18, 2010
Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approvalCaroline J Breitbach, Tony Reid, James Burke, et al.Pageof 22